235 related articles for article (PubMed ID: 25727848)
21. Enhanced Rejuvenation in Induced Pluripotent Stem Cell-Derived Neurons Compared with Directly Converted Neurons from an Aged Mouse.
Yang Y; Jiao J; Gao R; Le R; Kou X; Zhao Y; Wang H; Gao S; Wang Y
Stem Cells Dev; 2015 Dec; 24(23):2767-77. PubMed ID: 26192905
[TBL] [Abstract][Full Text] [Related]
22. Transcriptome Profiling Reveals Degree of Variability in Induced Pluripotent Stem Cell Lines: Impact for Human Disease Modeling.
Schuster J; Halvardson J; Pilar Lorenzo L; Ameur A; Sobol M; Raykova D; Annerén G; Feuk L; Dahl N
Cell Reprogram; 2015 Oct; 17(5):327-37. PubMed ID: 26348590
[TBL] [Abstract][Full Text] [Related]
23. Differentiation of primordial germ cells from induced pluripotent stem cells of primary ovarian insufficiency.
Leng L; Tan Y; Gong F; Hu L; Ouyang Q; Zhao Y; Lu G; Lin G
Hum Reprod; 2015 Mar; 30(3):737-48. PubMed ID: 25586786
[TBL] [Abstract][Full Text] [Related]
24. Derivation of murine induced pluripotent stem cells (iPS) and assessment of their differentiation toward osteogenic lineage.
Li F; Bronson S; Niyibizi C
J Cell Biochem; 2010 Mar; 109(4):643-52. PubMed ID: 20039314
[TBL] [Abstract][Full Text] [Related]
25. Determining epigenetic memory in kidney proximal tubule cell derived induced pluripotent stem cells using a quadruple transgenic reprogrammable mouse.
Khelifi G; Chow T; Whiteley J; Fort V; Humphreys BD; Hussein SMI; Rogers IM
Sci Rep; 2022 Nov; 12(1):20340. PubMed ID: 36434072
[TBL] [Abstract][Full Text] [Related]
26. Integrated analysis of hematopoietic differentiation outcomes and molecular characterization reveals unbiased differentiation capacity and minor transcriptional memory in HPC/HSC-iPSCs.
Gao S; Hou X; Jiang Y; Xu Z; Cai T; Chen J; Chang G
Stem Cell Res Ther; 2017 Jan; 8(1):13. PubMed ID: 28114969
[TBL] [Abstract][Full Text] [Related]
27. Donor-Dependent and Other Nondefined Factors Have Greater Influence on the Hepatic Phenotype Than the Starting Cell Type in Induced Pluripotent Stem Cell Derived Hepatocyte-Like Cells.
Heslop JA; Kia R; Pridgeon CS; Sison-Young RL; Liloglou T; Elmasry M; Fenwick SW; Mills JS; Kitteringham NR; Goldring CE; Park BK
Stem Cells Transl Med; 2017 May; 6(5):1321-1331. PubMed ID: 28456008
[TBL] [Abstract][Full Text] [Related]
28. Epigenetic Memory: Lessons From iPS Cells Derived From Human β Cells.
Efrat S
Front Endocrinol (Lausanne); 2020; 11():614234. PubMed ID: 33584546
[TBL] [Abstract][Full Text] [Related]
29. Nucleosome organizations in induced pluripotent stem cells reprogrammed from somatic cells belonging to three different germ layers.
Tao Y; Zheng W; Jiang Y; Ding G; Hou X; Tang Y; Li Y; Gao S; Chang G; Zhang X; Liu W; Kou X; Wang H; Jiang C; Gao S
BMC Biol; 2014 Dec; 12():109. PubMed ID: 25528259
[TBL] [Abstract][Full Text] [Related]
30. Epigenetic Variation between Human Induced Pluripotent Stem Cell Lines Is an Indicator of Differentiation Capacity.
Nishizawa M; Chonabayashi K; Nomura M; Tanaka A; Nakamura M; Inagaki A; Nishikawa M; Takei I; Oishi A; Tanabe K; Ohnuki M; Yokota H; Koyanagi-Aoi M; Okita K; Watanabe A; Takaori-Kondo A; Yamanaka S; Yoshida Y
Cell Stem Cell; 2016 Sep; 19(3):341-54. PubMed ID: 27476965
[TBL] [Abstract][Full Text] [Related]
31. Overlapping genes may control reprogramming of mouse somatic cells into induced pluripotent stem cells (iPSCs) and breast cancer stem cells.
Mosca E; Cocola C; Sabour D; Pelucchi P; Bertalot G; Palumbo O; Carella M; Götte M; Schöler HR; Reinbold R; Zucchi I; Milanesi L
In Silico Biol; 2010; 10(5-6):207-21. PubMed ID: 22430355
[TBL] [Abstract][Full Text] [Related]
32. Disease characterization using LQTS-specific induced pluripotent stem cells.
Egashira T; Yuasa S; Suzuki T; Aizawa Y; Yamakawa H; Matsuhashi T; Ohno Y; Tohyama S; Okata S; Seki T; Kuroda Y; Yae K; Hashimoto H; Tanaka T; Hattori F; Sato T; Miyoshi S; Takatsuki S; Murata M; Kurokawa J; Furukawa T; Makita N; Aiba T; Shimizu W; Horie M; Kamiya K; Kodama I; Ogawa S; Fukuda K
Cardiovasc Res; 2012 Sep; 95(4):419-29. PubMed ID: 22739119
[TBL] [Abstract][Full Text] [Related]
33. Cell reprogramming into the pluripotent state using graphene based substrates.
Yoo J; Kim J; Baek S; Park Y; Im H; Kim J
Biomaterials; 2014 Sep; 35(29):8321-9. PubMed ID: 24996757
[TBL] [Abstract][Full Text] [Related]
34. Generation of induced pluripotent stem cells from human foetal fibroblasts using the Sleeping Beauty transposon gene delivery system.
Davis RP; Nemes C; Varga E; Freund C; Kosmidis G; Gkatzis K; de Jong D; Szuhai K; Dinnyés A; Mummery CL
Differentiation; 2013; 86(1-2):30-7. PubMed ID: 23933400
[TBL] [Abstract][Full Text] [Related]
35. Multiple roles of p53-related pathways in somatic cell reprogramming and stem cell differentiation.
Yi L; Lu C; Hu W; Sun Y; Levine AJ
Cancer Res; 2012 Nov; 72(21):5635-45. PubMed ID: 22964580
[TBL] [Abstract][Full Text] [Related]
36. Malignant germ cell-like tumors, expressing Ki-1 antigen (CD30), are revealed during in vivo differentiation of partially reprogrammed human-induced pluripotent stem cells.
Griscelli F; Féraud O; Oudrhiri N; Gobbo E; Casal I; Chomel JC; Biéche I; Duvillard P; Opolon P; Turhan AG; Bennaceur-Griscelli A
Am J Pathol; 2012 May; 180(5):2084-96. PubMed ID: 22425713
[TBL] [Abstract][Full Text] [Related]
37. Metabolomic and Transcriptional Analyses Reveal Atmospheric Oxygen During Human Induced Pluripotent Stem Cell Generation Impairs Metabolic Reprogramming.
Spyrou J; Gardner DK; Harvey AJ
Stem Cells; 2019 Aug; 37(8):1042-1056. PubMed ID: 31042329
[TBL] [Abstract][Full Text] [Related]
38. Global transcriptional analysis of nuclear reprogramming in the transition from MEFs to iPSCs.
Dong F; Song Z; Zhang J; Lu Y; Song C; Jiang B; Zhang B; Cong P; Sun H; Shi F; Liu H
Genes Cells; 2013 Jan; 18(1):42-55. PubMed ID: 23231677
[TBL] [Abstract][Full Text] [Related]
39. Genetic Variability Overrides the Impact of Parental Cell Type and Determines iPSC Differentiation Potential.
Kyttälä A; Moraghebi R; Valensisi C; Kettunen J; Andrus C; Pasumarthy KK; Nakanishi M; Nishimura K; Ohtaka M; Weltner J; Van Handel B; Parkkonen O; Sinisalo J; Jalanko A; Hawkins RD; Woods NB; Otonkoski T; Trokovic R
Stem Cell Reports; 2016 Feb; 6(2):200-12. PubMed ID: 26777058
[TBL] [Abstract][Full Text] [Related]
40. Histone variant H2A.X deposition pattern serves as a functional epigenetic mark for distinguishing the developmental potentials of iPSCs.
Wu T; Liu Y; Wen D; Tseng Z; Tahmasian M; Zhong M; Rafii S; Stadtfeld M; Hochedlinger K; Xiao A
Cell Stem Cell; 2014 Sep; 15(3):281-294. PubMed ID: 25192463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
